Back
NovaBay Pharmaceuticals Stock Price Chart
Should You Invest in this AI Marketing High-Growth Startup by April?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
$0.63
Seasonality Move:
-8.46%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Buy |
| 20-day SMA: | 0.63 | Buy |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 1.09 | Sell |
| 8-day EMA: | 0.62 | Buy |
| 20-day EMA: | 0.63 | Buy |
| 50-day EMA: | 0.64 | Buy |
| 200-day EMA: | 3.06 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 52.48 | Buy |
| Chaikin Money Flow: | -170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.61 - 0.67) | Buy |
| Bollinger Bands (100): | (0.57 - 0.71) | Buy |
NovaBay Pharmaceuticals Technical Analysis
| Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.64 while NBY 8-day simple moving average is 0.60, which is a Buy signal.
-
The stock price of NBY is 0.64 while NovaBay Pharmaceuticals 20-day SMA is 0.63, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day simple moving average is 0.65 while NBY share price is 0.64, making it a Sell technically.
-
NBY stock price is 0.64 and NovaBay Pharmaceuticals 200-day simple moving average is 1.09, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a SellThe current NovaBay Pharmaceuticals [NBY] share price is $0.64. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
3.1M
Price in USD:
0.64
Share Volume:
7.2K
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
9.08
52-Week Low:
0.36
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?The NovaBay Pharmaceuticals stock price is 0.64 USD today.
-
Will NBY stock go up or go down?NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is NovaBay Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
-
NovaBay Pharmaceuticals share price is 0.64 while NBY 8-day exponential moving average is 0.62, which is a Buy signal.
-
The stock price of NBY is 0.64 while NovaBay Pharmaceuticals 20-day EMA is 0.63, which makes it a Buy.
-
NovaBay Pharmaceuticals 50-day exponential moving average is 0.64 while NBY share price is 0.64, making it a Buy technically.
-
NBY stock price is 0.64 and NovaBay Pharmaceuticals 200-day simple moving average is 3.06, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
-
NBY Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting NovaBay Pharmaceuticals is a Sell
-
NovaBay Pharmaceuticals Relative Strength Index (RSI) is 52.48, which suggest NovaBay Pharmaceuticals is overbought
-
The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.61 - 0.67), which suggest NovaBay Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.57 - 0.71), which suggest NovaBay Pharmaceuticals is a Buy
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.